AfroCentric Investment Corp (ACT)
Johannesburg Exchange · South Africa · prices in ZAC · close of 23 Oct 2026
Key indicators
| Last close | ZAC 69.00 |
|---|---|
| 52-week range | 56.00 – 165.00 |
| Return, 1 month / 3 months | −1.4% / −13.7% |
| Return, 1 year / 3 years | −58.2% / −79.2% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 113.0% |
| Worst drawdown (1 year) | -66.1% |
| Average daily value traded | 7.73M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AfroCentric Investment Corporation is a South African investment holding company focused on healthcare. Through its subsidiaries it administers medical schemes, manages health risks and provides related healthcare services to scheme members and corporate clients. The group also holds interests in pharmaceutical and health management businesses. It is based in South Africa and serves the country's medical scheme and healthcare market.
AfroCentric Investment Corp trades under the code ACT on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AfroCentric Investment Corp (ACT) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 69.00 on 23 October 2026.
Its price-based Market X-Ray is 9 out of 100 (a weak price profile), ranking 232 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 58.2% and over the last three months it fell 13.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 6 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.2% | ||
| From 52-week high | -58.2% | ||
| Momentum | 12 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.8% | ||
| 6-month return | -13.8% | ||
| 12-month return, skipping the last month | -57.6% | ||
| Stability (higher is calmer) | 7 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 113.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -66.1% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 7.73M ZAC | ||
| Zero-volume days | 11.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +13.1% |
|---|---|
| 1 month | −1.4% |
| 3 months | −13.7% |
| 6 months | −13.7% |
| 1 year | −58.2% |
| 3 years | −79.2% |
| 5 years | −85.6% |
Signals
| 50-day / 200-day average | 71.92 / 91.05 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Nov 2022 | ZAC 17.0000 |
| 11 May 2022 | ZAC 17.0000 |
| 10 Nov 2021 | ZAC 17.0000 |
| 12 May 2021 | ZAC 17.0000 |
| 11 Nov 2020 | ZAC 17.0000 |
| 6 May 2020 | ZAC 17.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.